Clinical studies have indicated that various leukaemias and lymphomas are responsive to alpha-interferon (IFN) (Smyth et al., 1987) . In contrast, epithelial tumours are generally unresponsive to this agent unless it is administered locally. In the case of small cell lung carcinoma (SCLC), the Phase II studies using IFN have been largely negative (Olesen et al., 1987; Jones et al., 1983; Jackson et al., 1984; Mattson, 1987) . However, an ongoing Phase III study exploring the use of IFN as maintenance therapy for SCLC (after initial response was obtained with chemo-and radiotherapy) is suggesting a trend towards long term survival compared to no treatment or treatment with maintenance chemotherapy (Mattson et al., 1988; Mattson, 1987) . These results suggest that IFN may have a role as adjuvant therapy in a subset of epithelial tumours. It is therefore of interest that while several groups have examined the growth modifying effects of IFN on cell lines derived from SCLC (Twentyman et al., 1985; Bepler et al., 1986; Munker et al., 1987; Jabbar et al., 1989) , none have reported on marked sensitivity to IFN.
However, we here describe a new cell line, WX322, the growth of which in agar is approximately 1000-fold more sensitive to IFN than that for previously described SCLC cell lines. The cell line has been characterised to confirm its human origin and SCLC derivation and its sensitivity to other cytotoxic agents determined. The cell line has also been established in immunosuppressed mice and its sensitivity to IFN has been investigated.
Materials and methods
Origin of the tumour The original tumour material was obtained in 1985 from a subcutaneous deposit in a 64-year old man suffering from metastatic small cell lung carcinoma (SCLC). The patient had not been treated previously with any form of therapy. The tumour was initially implanted as a xenograft in CBA mice immunosuppressed by thymectomy and whole body irradiation (Fergusson et al., 1986) and maintained in nude mice from 1988 onwards. Histological analysis confirmed the pathology of SCLC in the patient tumour and the pathology of the xenograft was checked at each passage and has not changed over 5 years.
Initiation of the cell line The cell line was derived from the xenograft at the 8th passage. The tumour was disaggregated into small fragments with a scalpel and suspended in RPMI 1640 supplemented with hydrocortisone (10nM), insulin (5ftgml1'), transferrin (10 psg ml-'), sodium selenite (30 nM), glutamine (2 mM), penicillin (1OOIUml-') and 3-[N-morpholino] propane sulfonic acid (12.5 mM) (referred to as RPMI + HITS). These cells were then cultured at 37°C, 90% humidity and 5% CO2. Although cultures were initially contaminated with stromal fibroblasts and macrophages, these adhered to plastic and so could be readily separated from the suspension cultures within the first two passages. Once established, cultures were routinely passaged by a 1:5 to 1:10 split every 2 weeks. Routine assays for mycoplasma were carried out and found to be negative. The present studies were conducted on cells between their 6th and 20th passage. The NCI-H69 cell line was kindly supplied by Prof. A. Harris, Newcastle and used at passages of between 65 and 75.
Estimation of L-3,4-dihydroxyphenylalanine decarboxylase activity L-3,4-dihydroxyphenylalanine decarboxylase activity was estimated by a modification of the method of Laduron and Belpaire (1968) . Cells were centrifuged at 200 g for 5 min and the pellet washed twice with phosphate buffered saline. The pellet was resuspended in borate buffer (0.025 M, pH 7.6) and the cells lysed by freezing at -70°C and thawing at 37°C three times. The lysate was mixed with pyridoxal-5-phosphate (final concentration of 400 pM). Enzyme activity was measured as the rate of conversion of 3H L-3,4-dihydroxyphenylalanine to 3H L-dopamine and the 3H L-dopamine is separated from 3H L-3,4-dihydroxyphenylalanine by liquid cation exchange (Fonnum, 1969 The isoenzyme profile was determined electrophoretically using a kit (Cardiotrak-CK, Corning Diagnostics Ltd, Hal- stead, Essex). The relative amounts of the three isoenzymes was determined with a scanning fluorimeter (Helena Densitometer, Beaumont, Texas, USA).
Electron microscopy For transmission electron microscopy, the tumour cells were pelleted and incubated in 2% glutaraldehyde in phosphate buffered saline. Post fixation was performed in 2% osmium tetroxide in phosphate buffered saline. The material was embedded in Epon.
Measurement of chemosensitivity in agar
The soft agar assay of Courtenay et al. (1978) (Gibco, Paisley, Scotland) at a density of 6-8 x 104 ml-' for WX322 and at a density of 2 x 104 mll-for NCI-H69 in either RPMI 1640 + HITS (described above) or RPMI 1640 + 10% FCS. IFN was added at the same time at concentrations ranging from 1 to 100,000 IU ml-'. On the days shown in Figures 2-4, the cell suspension was removed from groups of wells. Cell clusters were disaggregated by passage several times through a 19 gauge needle (Becton, Dickinson and Co, Dublin, Eire) prior to counting in a model ZF Coulter Counter.
Immunoperoxidase staining
The immunohistochemical studies of the cultured cells were performed according to the peroxidase anti-peroxidase method as follows (Sternberger, 1979) . Cells were placed onto multispot slides (Hendley [Essex] Ltd, Essex, UK) at approximately 2 x 104 cells/spot and fixed in methanol: acetone (1:1) for 10 min. The fixed preparations were then incubated at room temperature with hydrogen peroxide (0.5% in methanol) for 15 min to block endogenous peroxidase, washed in Tris buffered saline (TBS, Tris 0.5 M, pH 7.6 diluted in saline 1:10) and successively incubated with sheep serum: TBS (1:4) for 10 min and an appropriate dilution (described below) of the mouse MoAb for 30 min. Thereafter sheep anti-mouse IgG (SAPU, Carluke, UK) was applied at a dilution of 1:5 in TBS for 30 min at room temperature. After being washed with TBS, these samples were incubated with mouse monoclonal PAP complex (Dako Ltd, High Wycombe, UK) at optimal dilution (1:200) in TBS. Finally the peroxidase was localised by treatment of the samples with a fresh mixture of 3,3'-diaminobenzidine (0.1%) and hydrogen peroxide (0.1%) in Tris-imidazole buffer (pH 7.6) for 10 min, and after washing with water, these samples were counterstained with hematoxylin.
MoAbs were obtained from the following sources and used at these dilutions. 123C3 and 123A8 were gifts from Dr J. Hilgers, Netherlands Cancer Institute, Amsterdam and were used at a dilution of 1:100 of the ascites Mooi et al., 1988) . CAM 5.2 (Makin et al., 1984) , AUA1 (Spurr et al., 1986) , UJ13A (Allan et al., 1983) , HMFG1 and HMFG2 (Burchell et al., 1983) were gifts from ICRF, London and were used as supernatants. Leukocyte common antigen (DAKO-LC), used as a negative control throughout, was obtained from DAKO and used as a 1:20 dilution of supernatant.
Cell cycle phase distribution after exposure to IFN Cells were set up in 6-well plates with or without I03 or 104IU ml' IFN. Samples of approximately 106 cells were prepared from quadruplicate wells at each time point for DNA analysis by a trypsin/detergent method using propidium iodide as a stain (Vindelov et al., 1983) . Analysis was carried out using a FACScan flow cytometer equipped for doublet discrimination (Becton Dickinson) using Cellfit software. All data was gated on forward and side scatter signals to exclude fragmented and clumped material and on a fluorescence width vs fluorescence area signal to exclude doublets. Cell cycle distribution analysis was performed using the RFIT model which calculates S phase as a rectangle bounded by the mean GO/GI and G2/M channels with a height of the mean S phase channel. The mean coefficient of variation of the GO/GI histogram was 4.8.
In vivo testing Female nu/nu (nude) mice (originally bred at ICRF Laboratories, London) were obtained from OLAC Ltd, and maintained in negative pressure isolators (La Calhene, Cambridge). The WX322 xenograft was maintained as a subcutaneous tumour in the flank of these mice and used at passages 25-28 for the experiments described. In these experiments, fragments of the WX322 xenograft (obtained from passage animals) were implanted subcutenously into the flanks of animals. After approximately 1 month, when tumours reached a volume of 100-200mm3, animals were randomly allocated to treatment or saline control groups (each of six animals) and treatment commenced (defined as Day 0). The doses and schedules used for each agent are described in Table IV . Tumours were measured three times a week using vernier calipers. Tumour volumes were estimated by using the formula: volume (V) = n/6 x 1 x w2 where 1 is the longest diameter and w is the diameter perpandicular to 1985). Electron microscopy revealed the presence of desmosomes consistent with an epithelial origin (Figure lb) , though dense core granules were not observed. The xenograft from which the cell line was initiated possessed a pathology typical of SCLC (Figure 1c ).
Biochemical and immunohistochemical properties of the cell line The SCLC markers L-3,4-dihydroxyphenylalanine decarboxylase and creatine kinase BB were both found in the WX322 cell line (Table I) . Comparison with the classic NCI-H69 cell line indicated that levels of L-3,4-dihydroxyphenylalanine decarboxylase were similar in the two lines while levels of creatine kinase in the WX322 cells were approximately 1/3 level of H69 cells (Table I ). The isoenzyme profile for the various forms of creatine kinase was similar for the two cell lines (Table I ). WX322 cells were stained with a number of Figure 5 . Concentrations greater than 10 IU ml-' inhibited cell growth of WX322 cells in either serum-free or serum-containing media while a concentration greater than 1000 IU ml-' was needed to inhibit growth of the NCI-H69 cell line in serumcontaining medium. Increasing the IFN concentration above these values produced increasing inhibition indicating a concentration-response relationship. Concentrations of 104 IU ml-' in serum-free conditions and 102 IU ml-' in serumcontaining conditions were cytostatic for WX322 cells while a concentration greater than 105 IU ml1-would be required to produce cytostasis for NCI-H69 cells. Therefore while the WX322 line appears less sensitive to IFN when suspended in medium without agar compared to suspension in agar, the large differential between WX322 and NCI-H69 cells remains.
Cell cycle distribution after exposure to IFN Chemosensitivity of the WX322 xenograft IFN was tested against the WX322 xenograft at doses of 105, 2 x I05 and 4 x I05 IU mouse day. The highest dose tested produced a specific growth delay of 2.6 for 21-day injection schedule and 2.1 for a 14-day schedule (Table IV) . The complete dose-response curves for the 21-day schedule are shown in Figure 8 . Cisplatin, adriamycin, vinblastine, vindesine and cyclophosphamide were tested against the WX322 xenograft at their maximum tolerated doses. The former two agents demonstrated marginal activity and the latter three marked activity as indicated by the specific growth delays (Table IV) .
Discussion
The growth inhibitory effect of IFN on SCLC has previously been studied using 15 SCLC cell lines in four separate studies (Twentyman et al., 1985; Bepler et al., 1986; Munker et al., 1987; Jabbar et al., 1989) . However none of these lines were particularly sensitive to this agent. When the properties of the WX322 cell line were first investigated, IFN appeared to have a marked inhibitory effect on the colony formation of a single cell suspension of these cells when grown in agar and this had been further investigated in the present report. Although the cell line had been derived from a SCLC xenograft with obvious SCLC pathology it was important to confirm that the biochemical and antigen features were consistent with SCLC origin. Levels of the biochemical markers L-3,4-dihydroxyphenylalanine decarboxylase and creatine kinase in WX322 cells were typical of SCLC Gazdar et al., 1985) as was the presence of both epithelial and neuroendocrine antigens (de Leij et al., 1988) . When WX322 cells were grown in agar, colony formation was inhibited by concentrations of IFN less than 10 IU ml' while concentrations of greater than 104 IU ml1 were needed to produce comparable effects in the NCI-H69 cell line. This large difference in sensitivity though did not extend to cytotoxic agents since both cell lines were inhibited by comparable concentrations of these drugs. Two previous studies have reported the effects of IFN on SCLC cell lines growing in agar (Bepler et al., 1986; Munker et al., 1987) , but in 12 lines, concentrations as high as 4 x 103 IU ml-' IFN (Munker et al., 1987) failed to produce 50% inhibition of growth. Although it has been suggested that sensitivity of SCLC lines correlates directly to proliferation rate (Bepler et al., 1986) , this is clearly not the case in the present study, since the sensitive WX322 line possesses a much reduced growth rate compared to the insensitive NCI-H69 line.
The WX322 cell line was less sensitive to IFN in suspension culture than in agar though still much more responsive than the NCI-H69 cell line. A concentration of IFN of between 102 and I03 IU ml-' produced 50% inhibition of growth in serum-free medium and between 10' and 102IU ml-' in serum containing medium. Other reports in which IFN has been studied against SCLC cell lines growing in suspension have demonstrated inhibition of 50-70% using 4 x 103 IU ml-' (Jabbar et al., 1989) but not with IO' IU ml-' (Twentyman et al., 1985) .
The WX322 cell line grew more rapidly in serum-free medium than in serum-containing medium and so has been maintained in serum-free conditions. In our study, the cell line was more, rather than less, sensitive in serum-containing medium as opposed to serum-free conditions. Serum has been shown to modify sensitivity to IFN (Bakhanashvili et al., 1983 ) with higher levels of serum decreasing sensitivity to IFN though others (using y-interferon) have not found this (Twentyman et al., 1985) .
Analysis of the cell cycle distribution for these two lines indicated differing effects. While IFN in the WX322 line produced a marked increase in the percentage of cells in the GO/GI phase of the cell cycle but S phase retardation has also been reported (Roos et al., 1984; Lundblad & Lundgren, 1981) . To achieve complete inhibition of WX322 xenograft growth, doses of IFN of 4 x IO' IU day are needed though doses of IO' and 2 x IO' IU day also produce marked activity. To the best of our knowledge, the WX322 xenograft is the first example of a lung carcinoma xenograft whose growth can be completely inhibited by IFN. The level of activity is comparable to that demonstrated by Balkwill using IFN against breast and colorectal xenografts (Balkwill et al., 1982; Balkwill & Proietti, 1986) . We believe that this cell line and xenograft represent useful model systems by which to investigate further the mechanisms of antitumour activity of IFN. We are currently investigating IFN receptor levels in the WX322 and NCI-H69 cell lines in order to see if there are marked differences between the lines.
